D Ducttape Full Member Lifetime Donor Verified Member 10+ Year Member Gold Donor Joined Oct 7, 2011 Messages 16,648 Reaction score 7,146 Oct 25, 2013 #2 is it tamper resistant? i hope it is, or the irony is stunning.
SeniorWrangler Full Member 10+ Year Member Joined Nov 10, 2010 Messages 1,195 Reaction score 823 Oct 25, 2013 #3 I think it's ironic that the FDA is approving Zohydro at the same time that it's talking about moving Vicodin to Schedule II. And no, it's not tamper-resistant: http://www.bloomberg.com/news/2013-...-approval-for-pure-hydrocodone-pain-pill.html On the bright side, my Zogenix stock is doing pretty well. 🙂 (Just kidding, I only own mutual funds)
I think it's ironic that the FDA is approving Zohydro at the same time that it's talking about moving Vicodin to Schedule II. And no, it's not tamper-resistant: http://www.bloomberg.com/news/2013-...-approval-for-pure-hydrocodone-pain-pill.html On the bright side, my Zogenix stock is doing pretty well. 🙂 (Just kidding, I only own mutual funds)
lobelsteve Full Member Staff member Volunteer Staff Lifetime Donor Verified Member Verified Expert 20+ Year Member Gold Donor Joined May 30, 2005 Messages 23,245 Reaction score 14,819 Oct 25, 2013 #4 Wrote an article on this drug for omfs journal 2 years ago and fda told Abbott no way at that time. Just another opiate. Nothing exciting. You can take away qid vicodin for bid zohydro.
Wrote an article on this drug for omfs journal 2 years ago and fda told Abbott no way at that time. Just another opiate. Nothing exciting. You can take away qid vicodin for bid zohydro.
1 101N Membership Revoked Removed 10+ Year Member Joined Apr 7, 2011 Messages 5,313 Reaction score 1,086 Oct 25, 2013 #5 A huge roar of applause goes up on the opiophile website.
Aether2000 algosdoc Verified Member 20+ Year Member Joined May 3, 2005 Messages 4,273 Reaction score 2,348 Oct 25, 2013 #6 One of the more significant benefits of the extreme escalations of deductibles on health insurance plans and health insurers hoops to jump through for new medicationis is that this drug will be unaffordable for most patients.
One of the more significant benefits of the extreme escalations of deductibles on health insurance plans and health insurers hoops to jump through for new medicationis is that this drug will be unaffordable for most patients.